ESR1 overexpression is a biomarker of relapse and worse prognosis in stage I endometrioid endometrial carcinoma by C.B.P. Chaves, P. Nicolau-Neto, T.A. Simão, P.T. de Souza-Santos, A. Bergmann, L. Brewer, F.C.B. Moreira, B.S.B. Reis, M.A.M. Moreira, L.F.R. Pinto

Get full text